Niki BioSolutions NIKI

Up to $1,396,000 in common stock offered

Securities offering

Form
424B5
Filed
Importance
Routine
  1. Up to $1,396,000 in common stock offered
  2. Sales agreement with H.C. Wainwright & Co., LLC and Brookline Capital Markets
  3. Common Stock listed on Nasdaq under Niki
  4. Compensation for sales is 3.0% of gross proceeds

Written from the 424B5 on EDGAR. Check the filing before you rely on it.

Get an email when Niki BioSolutions files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3829 and related industry codes: the same peer list as the financial tables.